Buy Alcon

Logo for stock ALC (Alcon)

Amount

£
GBP

Latest price

$89.79
(£1.00 = $1.241)

Number of shares (est.)

0

Start investing today

Open an investment account in Emma and enjoy commission free stock trading. Capital at risk, other charges apply.

QR code linking to downloads for the Emma app.
Download on the App Store buttonGet it on Google Play button

Metrics

Market Cap

$40.825B

P/E ratio

34.98

EPS

$2.336

Beta

1.14

Dividend rate

$0.178

Dividend yield

0.22%

About

Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.

CEO

Mr. David J. Endicott

Employees

25,315

Sector

Industrials

Company HQ

FRIBOURG, Switzerland

Website

News

Logo for news article #0 (Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference)

Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference

GENEVA--(BUSINESS WIRE)--Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference.

Business Wire

December 31, 2024

Logo for news article #1 (Here's Why Alcon (ALC) is a Strong Growth Stock)

Here's Why Alcon (ALC) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research

December 23, 2024

Logo for news article #2 (Reasons to Retain Alcon Stock in Your Portfolio for Now)

Reasons to Retain Alcon Stock in Your Portfolio for Now

Strong growth in the Surgical and Vision Care businesses raises investors' optimism for ALC.

Zacks Investment Research

December 13, 2024

Emma logo
Facebook logoTiktok logoTwitter / X logoInstagram logo

© 2025 Emma Technologies Ltd. All Rights Reserved.

Emma is registered and incorporated in England and Wales.

Emma Technologies Ltd is an appointed representative of RiskSave Technologies Ltd, which is authorised and regulated by the Financial Conduct Authority (FRN 775330).

Payment services (Non MIFID or Deposit related products) for Emma Technologies Ltd are provided by The Currency Cloud Limited. Registered in England No. 06323311. Registered Office: Stewardship Building 1st Floor, 12 Steward Street London E1 6FQ. The Currency Cloud Limited is authorised by the Financial Conduct Authority under the Electronic Money Regulations 2011 for the issuing of electronic money (FRN: 900199). For more detail on how your money is protected please see here. You can also find Currency Cloud's Terms of Use here.

Emma Technologies Ltd is an Introducer Appointed Representative of Quint Group Limited, which is authorised and regulated by the Financial Conduct Authority (FRN 669450). Emma Technologies Ltd is not a lender. Emma Technologies Ltd introduces customers to Monevo Limited who is a licensed credit broker.

Emma is registered with the Financial Conduct Authority under the Payment Services Regulations 2017 for the provision of payment services.

Financial Conduct Authority Reg Nr: 794952.
Company Registration Number: 10578464.
Data Protection Registration Number: ZA241546.

All testimonials, reviews, opinions or case studies presented on our website may not be indicative of all customers. Results may vary and customers agree to proceed at their own risk.